TrialThe Journal of allergy and clinical immunology2016

A randomized, double-blind, placebo-controlled study of omalizumab combined with oral immunotherapy for the treatment of cow's milk allergy.

Robert A Wood et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.